• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER SUSTAINABILITY SOLUTIONS LAKELAND ETHICON HARMONIC ACE SHEARS; SCALPEL, ULTRASONIC, REPROCESSED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER SUSTAINABILITY SOLUTIONS LAKELAND ETHICON HARMONIC ACE SHEARS; SCALPEL, ULTRASONIC, REPROCESSED Back to Search Results
Catalog Number HAR36
Device Problem Difficult or Delayed Activation (2577)
Patient Problem No Information (3190)
Event Date 05/11/2016
Event Type  malfunction  
Event Description
Couldn't activate device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETHICON HARMONIC ACE SHEARS
Type of Device
SCALPEL, ULTRASONIC, REPROCESSED
Manufacturer (Section D)
STRYKER SUSTAINABILITY SOLUTIONS LAKELAND
5300 region court
lakeland FL 33815
MDR Report Key5688168
MDR Text Key46173261
Report Number5688168
Device Sequence Number1
Product Code LFL
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other
Type of Report Initial
Report Date 05/23/2016,05/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/31/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date03/09/2017
Device Catalogue NumberHAR36
Device Lot Number4424934
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/13/2016
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/23/2016
Event Location Hospital
Date Report to Manufacturer05/23/2016
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage N
Patient Sequence Number1
Treatment
N/A.
Patient Age33 YR
-
-